+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Denosumab Injection Market - Global Forecast 2025-2030 - Product Thumbnail Image

Denosumab Injection Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
From
From
Chemotherapy-induced Thrombocytopenia (CIT) - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy-induced Thrombocytopenia (CIT) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Kidney Cancer Drugs Market Report 2026 - Product Thumbnail Image

Kidney Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Neutropenia Biologic Drug Treatment Market Report 2026 - Product Thumbnail Image

Neutropenia Biologic Drug Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Phosphodiesterase (PDE) Inhibitors Market 2024-2028 - Product Thumbnail Image

Phosphodiesterase (PDE) Inhibitors Market 2024-2028

  • Report
  • December 2023
  • 165 Pages
  • Global
From
From
From
From
Loading Indicator